EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Bioenergetics and lipid metabolism in Alzheimer's disease: From cell biology to systemic health

Silvia Maioli, Ivan Nalvarte iD, Maria Ankarcrona, Marianne Schultzberg, Kristen L Zuloaga, Julen Goikolea, Pieter Jelle Visser, Bart De Strooper, Bengt Winblad, Paola Pizzo, Pete A Williams, Patricia Rodriguez-Rodriguez und 1 weitere

Journal of Internal Medicine · 2026-01 · 299 (1) · 20-43

DOI: 10.1111/joim.70036 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Internal Medicine, online erschienen am 06.11.2025. Verfasst von Silvia Maioli und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Karolinska Institutet, Stockholm, …. Hauptthemen laut MEDLINE: Alzheimer Disease, Lipid Metabolism, Energy Metabolism. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 235 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS, Gun och Bertil Stohnes Stiftelse, Ulla and Ingemar Dahlberg Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a complex neurodegenerative disorder characterized by progressive cognitive decline. Although amyloid‐β and tau pathologies remain central to our understanding of AD, growing evidence suggests that disrupted lipid metabolism and impaired bioenergetics are closely linked to these hallmark features. Genetic, lipidomic and functional studies point to alterations in cholesterol, phospholipids and polyunsaturated fatty acids, which can influence mitochondrial function, organelle communication and glial responses. These processes are further modulated by apolipoprotein E (APOE) genotype, sex differences and systemic metabolic states such as obesity and diabetes, contributing to neuroinflammation and cognitive decline. Although findings are sometimes conflicting, an emerging theme is that lipid and energy metabolisms are central to how genetic and environmental risk factors shape AD pathogenesis. This integrated perspective highlights lipid and bioenergetic pathways as promising therapeutic targets, where metabolic modulators, lipid‐directed interventions and lifestyle strategies may complement amyloid‐based therapies and offer opportunities for precision approaches, particularly in women and APOE ε4 carriers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseLipid MetabolismEnergy MetabolismHumansApolipoproteins EMitochondria

Stichwörter der Autor:innen

Alzheimer's diseaselipid metabolismmitochondriasystemic metabolism

Substanzen

Apolipoproteins E

Autor:innen und Institutionen

  • Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Karolinska Institutet, Stockholm, Sweden.
  • Department of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, New York, USA.
  • Department of Neurobiology, Brudnick Neuropsychiatric Research Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
  • Department of Psychiatry & Neuropsychology, Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.
  • Alzheimer Center and Department of Neurology, Amsterdam Neuroscience Campus, VU University Medical Center, Amsterdam, the Netherlands.
  • Laboratory for Neurodegenerative Diseases, VIB-KU Leuven, and Leuven Brain Institute, Leuven, Belgium.

ORCID-Profile: Ivan Nalvarte, Luana Naia

Förderung

  • NINDS NIH HHS
  • Gun och Bertil Stohnes Stiftelse
  • Ulla and Ingemar Dahlberg Foundation
  • Swedish Alzheimer Foundation
  • National Institutes of Health (NIH) research
  • Margaretha af Ugglas Foundation
  • Strategic Research Program in Neuroscience-StratNeuro
  • Dementia Foundation

Zitieren

APA

Maioli, S., Nalvarte, I., Ankarcrona, M., Schultzberg, M., Zuloaga, K. L., Goikolea, J., Visser, P. J., De Strooper, B., Winblad, B., Pizzo, P., Williams, P. A., Rodriguez-Rodriguez, P., & Naia, L. (2026). Bioenergetics and lipid metabolism in Alzheimer's disease: From cell biology to systemic health. Journal of Internal Medicine, 299(1), 20-43. https://doi.org/10.1111/joim.70036

Vancouver

Maioli S, Nalvarte I, Ankarcrona M, Schultzberg M, Zuloaga KL, Goikolea J, et al. Bioenergetics and lipid metabolism in Alzheimer's disease: From cell biology to systemic health. Journal of Internal Medicine. 2026;299(1):20-43. doi:10.1111/joim.70036

BibTeX
@article{Maioli2026,
  author = {Maioli, Silvia and Nalvarte, Ivan and Ankarcrona, Maria and Schultzberg, Marianne and Zuloaga, Kristen L and Goikolea, Julen and Visser, Pieter Jelle and De Strooper, Bart and Winblad, Bengt and Pizzo, Paola and Williams, Pete A and Rodriguez-Rodriguez, Patricia and Naia, Luana},
  title = {Bioenergetics and lipid metabolism in Alzheimer's disease: From cell biology to systemic health},
  journal = {Journal of Internal Medicine},
  year = {2026},
  volume = {299},
  number = {1},
  pages = {20--43},
  doi = {10.1111/joim.70036}
}
Kostenlos starten →